Research Article
The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients
Table 1
Relationships among plasma levels of PCNAP1 and patient clinicopathologic features.
| Clinicopathological parameters | Expression of PCNAP1 | | | High | Low |
| Gender () | | | 0.459 | 6.228 | Female | 10 | 10 | | | Male | 46 | 23 | | | Age (years) | | | 0.656 | 5.309 | ≤60 | 41 | 28 | | | >60 | 15 | 5 | | | TNM stages () | | | 0.026 | 10.337 | І | 9 | 4 | | | II | 8 | 9 | | | III | 30 | 11 | | | IV | 9 | 9 | | | Lymph node metastasis () | | | 0.043 | 6.718 | Yes | 49 | 24 | | | No | 7 | 9 | | | Tumor size (cm) | | | 0.037 | 8.164 | ≥5 | 39 | 17 | | | <5 | 17 | 16 | | |
|
|